Elevated fibroblast growth factor 23 in a patient with metastatic prostate cancer and hypophosphatemia.
Cotant
Casey L
CL
Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, MI 48103, USA.
Rao
Panduranga S
PS
D000230:Adenocarcinoma / Q000097:blood*; D000369:Aged, 80 and over; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000097:blood*; D006801:Humans; D017674:Hypophosphatemia / Q000097:blood*; D008297:Male; D010018:Osteomalacia / Q000097:blood* / Q000175:diagnosis* / Q000209:etiology; D010281:Parathyroid Hormone / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood*; D013577:Syndrome; D014807:Vitamin D / Q000031:analogs & derivatives / Q000097:blood
D010281:Parathyroid Hormone; D014807:Vitamin D; D005346:Fibroblast Growth Factors; C097949:1,25-dihydroxyvitamin D; D000089703:Fibroblast Growth Factor-23; C104450:25-hydroxyvitamin D